ArticleIranian journal of pharmaceutical research : IJPR
Impact of Mild Traumatic Brain Injury (mTBI) on CYP2D6 Activity and the Restorative Effects of Melatonin and Vitamin C Supplementation.
Article in Iranian journal of pharmaceutical research : IJPR. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Mild traumatic brain injury (mTBI) may disrupt hepatic cytochrome P-450 enzyme activity, potentially altering drug pharmacokinetics. Objectives: This study investigated the impact of mTBI on CYP2D6 activity and the restorative effects of melatonin and vitamin C supplementation. Methods: Mild traumatic brain injury was induced in rats using a modified weight-drop model, which were then assigned to treatment or control groups. CYP2D6 activity was assessed at multiple time points post-injury using metabolic ratios of tramadol and mirtazapine through isolated liver perfusion. All experimental procedures were conducted with the investigator blinded to group assignments. Results: Mild traumatic brain injury significantly suppressed CYP2D6 activity on day 3, with partial recovery by day 7. While tramadol metabolism normalized by day 28, mirtazapine metabolism remained impaired in non-supplemented groups. Supplementation accelerated CYP2D6 recovery, showing statistically significant change by day 7. By day 28, supplemented groups exhibited metabolic ratios surpassing baseline levels. Conclusions: Mild traumatic brain injury induces transient suppression of CYP2D6 activity, which was attenuated in antioxidant-treated groups in this preclinical model. Further studies are needed to explore the clinical relevance of these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.